Suppr超能文献

可乐定与β-肾上腺素能受体阻滞剂联合治疗高血压的长期经验。

Long-term experience with the combination of clonidine and beta-adrenoceptor blocking agents in hypertension.

作者信息

Vanholder R, Lameire N, Ringoir S

出版信息

Eur J Clin Pharmacol. 1985;28(2):125-30. doi: 10.1007/BF00609678.

Abstract

The risk of cardiovascular and fatal complications and the antihypertensive effect of a clonidine-beta-blocker combination was studied in 98 patients and was compared with the results for a group of patients treated with other antihypertensive regimens. The profile of complications was similar in the two groups for a total follow-up period of more than 2000 treatment-months. Clonidine in combination either with propranolol or atenolol had a distinct antihypertensive effect. However, clonidine plus atenolol resulted in a more immediate and pronounced fall in blood pressure. It is concluded that the combination of clonidine and a beta-blocker is an effective antihypertensive medication, and that patients treated with it are apparently at no greater risk of serious cardiovascular incidents than are those treated with other regimens.

摘要

对98例患者研究了可乐定与β受体阻滞剂联合用药的心血管及致命并发症风险和降压效果,并与一组接受其他降压方案治疗的患者结果进行比较。两组在超过2000个治疗月的总随访期内并发症情况相似。可乐定与普萘洛尔或阿替洛尔联合使用有明显的降压作用。然而,可乐定加阿替洛尔导致血压下降更迅速且显著。结论是,可乐定与β受体阻滞剂联合是一种有效的降压药物,接受该治疗的患者发生严重心血管事件的风险显然并不高于接受其他方案治疗的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验